Skip to main content
SLSBio(Specialty Lab Solution Bio) Co., Ltd logo

SLSBio(Specialty Lab Solution Bio) Co., Ltd — Investor Relations & Filings

Ticker · 246250 ISIN · KR7246250005 KO Professional, scientific and technical activities
Open in API
Filings indexed 261 across all filing types
Latest filing 2019-05-16 Major Shareholding Noti…
Country KR South Korea
Listing KO 246250

About SLSBio(Specialty Lab Solution Bio) Co., Ltd

http://www.slabs.co.kr/

SLSBio (Specialty Lab Solution Bio) Co., Ltd. is a company specializing in laboratory solutions and support services for the pharmaceutical and biotechnology sectors. Its primary offerings include pharmaceutical quality control testing, clinical trial sample analysis, bioequivalence studies, drug stability testing, and new drug development support. In addition to its service portfolio, the company develops and manufactures diagnostic technologies, reagents, and other biological agents, supporting various stages of the drug development and commercialization lifecycle.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). This document details changes in share ownership by major shareholders (Moon Hae-ran and Kim Nam-yong) in the company 'SLS Bio'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes.
2019-05-16 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) meeting. It provides details such as the date, time, location, target audience, and purpose of the event. Since it is an announcement of an upcoming event rather than the presentation materials themselves or a financial report, it falls under the category of general regulatory announcements or notices.
2019-05-13 Korean
지정자문인선임계약의해지
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the termination of a designated advisor contract (지정자문인 선임계약의 해지) for the company SLS Bio. It provides specific dates and reasons for the contract termination. Since it is a regulatory announcement regarding a corporate contract change that does not fit into specific categories like M&A, Board changes, or Share issues, it falls under the general regulatory filing category.
2019-05-10 Korean
지정자문인선임계약의체결
Capital/Financing Update Classification · 95% confidence The document is a short regulatory announcement regarding the appointment of a new designated advisor (Kyobo Securities) following the termination of a previous contract. It does not fit into specific financial reporting categories like 10-K or IR, nor is it a report publication announcement. As it is a formal regulatory disclosure regarding corporate governance/advisory structure, it falls under the RNS category.
2019-05-10 Korean
유동성공급계약의변경
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding a change in the liquidity provider (designated advisor) for the company SLS Bio. It details the transition from NH Investment & Securities to Kyobo Securities. Since it is a brief regulatory announcement regarding a corporate contract change and does not fit into specific categories like M&A or share issuance, it is classified as a general regulatory filing.
2019-05-10 Korean
사업보고서 (2018.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for (주)에스엘에스바이오 for the fiscal year ending December 31, 2018. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. It is not an Annual Report (10-K) as it focuses specifically on the audit and financial statements rather than the broader company activity report, and it is not an announcement (RPA) because it contains the full financial data. FY 2018
2019-04-01 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.